Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06872645 · ClinicalTrials.gov registry record · NA
Exploring Water-free Sodium Storage
A NA study of Peritoneal Dialysis, Heart Failure, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06872645 is a NA study of Peritoneal Dialysis, Heart Failure that is actively recruiting participants, run by Yale University. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06872645, a NA study of Peritoneal Dialysis, Heart Failure, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this proposal is to definitively establish if acute water free Na storage and release occurs, if the amount stored/released is of a quantity that is physiologically relevant, and if the location is intracellular vs. extracellular.
Conditions Studied
Interventions
- DRUG 5% Dextrose/Water
- DRUG 1.5% standard PD fluid
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-03 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06872645
The ClinicalTrials.gov registry entry for NCT06872645 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peritoneal Dialysis, Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which 5% Dextrose/Water is the first listed.
NCT06872645 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06872645 about?
NCT06872645 is a clinical study titled "Exploring Water-free Sodium Storage". The overarching goal of this proposal is to definitively establish if acute water free Na storage and release occurs, if the amount stored/released is of a quantity that is physiologically relevant, and if the location is intracellular vs. extracellular.
What is the current status of trial NCT06872645?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-10-03. Estimated completion is 2026-12.
What conditions does trial NCT06872645 study?
This clinical trial studies the following conditions: Peritoneal Dialysis, Heart Failure.
What interventions are being tested in trial NCT06872645?
The interventions under investigation include: 5% Dextrose/Water (DRUG), 1.5% standard PD fluid (DRUG).
Who is sponsoring clinical trial NCT06872645?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06872645 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.